Wellgistics Health, Inc. (WGRX)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Wellgistics Health, Inc. (WGRX) trades at $3.48 with AI Score 49/100 (Grade C). Wellgistics Health, Inc. Market cap: $8.75M, Sector: Healthcare.
Last analyzed: May 10, 2026Analyst Coverage for WGRX: WGRX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates WGRX against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
WGRX: the 1 perspectives are evenly split.
Wellgistics Health, Inc. (WGRX) Healthcare & Pipeline Overview
Wellgistics Health, Inc. distributes pharmaceutical products and provides third-party logistics within the U.S. healthcare sector. The company's DelivMeds platform offers clinical concierge services, targeting independent pharmacies and pharmaceutical manufacturers. Despite a challenging profit margin, Wellgistics aims to streamline pharmaceutical distribution and enhance pharmacy support services.
What Is the Investment Thesis for WGRX?
Wellgistics Health, Inc. presents a high-risk, high-reward investment profile. The company's negative profit margin of -433.9% and gross margin of -41.3% indicate significant operational challenges. However, its focus on independent pharmacies and pharmaceutical manufacturers, coupled with its DelivMeds platform, positions it to potentially capitalize on the growing demand for efficient pharmaceutical distribution and clinical support services. The company's small market capitalization of $0.01 billion suggests substantial growth potential if it can achieve operational efficiencies and expand its market share. Key to its success will be leveraging its third-party logistics services and the DelivMeds platform to drive revenue growth and improve profitability. Investors should closely monitor the company's ability to manage costs and achieve sustainable profitability in the competitive pharmaceutical distribution market.
Based on FMP financials and quantitative analysis
WGRX Key Highlights
- Market capitalization of $0.01 billion, indicating a micro-cap company with high growth potential but also significant risk.
- Negative profit margin of -433.9%, reflecting substantial operational inefficiencies and challenges to profitability.
- Negative gross margin of -41.3%, suggesting that the cost of goods sold exceeds revenue, requiring significant improvements in pricing and cost management.
- Beta of -3.78, indicating an inverse correlation with the market, which may offer diversification benefits but also reflects unique company-specific risks.
- No dividend yield, consistent with a growth-oriented company focused on reinvesting earnings to expand its operations and market presence.
Who Are WGRX's Competitors?
WGRX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| FCAMX Franklin California High Yield Municipal Fund Class A1 | $9.73 | +0.00% | $3.29B | 51 |
| SIXD AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF | $30.59 | -0.13% | $33.29M | 50 |
| IPOS Renaissance International IPO ETF | $23.66 | +1.69% | $7.01M | 47 |
| TDV ProShares - S&P Technology Dividend Aristocrats ETF | $103.28 | +1.18% | $293.10M | 47 |
| DAUG FT Vest U.S. Equity Deep Buffer ETF - August | $46.53 | +0.20% | $363.60M | 47 |
| FIRFX Fidelity Managed Retirement 2025 Fund | $63.03 | -1.65% | $43.23M | 47 |
| JEMSX JPMorgan Emerging Markets Equity Fund | $53.09 | +0.53% | $11.59B | 47 |
| FCTKX Fidelity Freedom 2055 K6 | $20.42 | +0.74% | $16.91B | 47 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WGRX's Key Strengths?
- DelivMeds platform offering clinical concierge services.
- Third-party logistics services tailored to pharmaceutical manufacturers.
- Distribution network of independent retail pharmacies.
- Focus on underserved markets.
What Are WGRX's Weaknesses?
- Negative profit and gross margins.
- Small market capitalization.
- Limited brand recognition.
- High dependence on a niche market.
What Could Drive WGRX Stock Higher?
- Expansion of the DelivMeds platform to include additional clinical services by Q4 2026.
- Strategic partnerships with pharmaceutical manufacturers to expand logistics services.
- Geographic expansion into new regions within the United States.
What Are the Key Risks for WGRX?
- Increased competition from established pharmaceutical distributors.
- Changes in pharmaceutical regulations affecting distribution practices.
- Negative profit and gross margins impacting financial stability.
- Economic downturn affecting healthcare spending.
What Are the Growth Opportunities for WGRX?
- Expansion of DelivMeds Platform: The DelivMeds platform offers a significant growth opportunity by providing clinical concierge services and streamlining prescription transfers for independent pharmacies. By expanding the platform's reach and functionality, Wellgistics can attract more pharmacies to its network and increase its revenue streams. The market for pharmacy support services is estimated to grow to $10 billion by 2030, presenting a substantial opportunity for Wellgistics to capture a significant share.
- Strategic Partnerships with Pharmaceutical Manufacturers: Collaborating with small and mid-size pharmaceutical manufacturers to provide comprehensive logistics solutions can drive revenue growth. By offering warehousing, inventory management, and shipping services, Wellgistics can become an integral part of the manufacturers' supply chain, securing long-term contracts and recurring revenue. The market for pharmaceutical logistics is projected to reach $150 billion by 2028, offering ample opportunities for Wellgistics to expand its service offerings.
- Geographic Expansion within the United States: Expanding its distribution network to new regions within the United States can increase Wellgistics' market reach and customer base. By targeting underserved markets with a high concentration of independent pharmacies, the company can establish a strong presence and capture market share. The U.S. pharmaceutical market is the largest in the world, providing a vast landscape for geographic expansion and revenue growth.
- Acquisition of Complementary Businesses: Acquiring smaller companies that offer complementary services, such as specialty pharmacy solutions or healthcare technology platforms, can enhance Wellgistics' capabilities and market position. Strategic acquisitions can provide access to new technologies, customer segments, and geographic markets, accelerating the company's growth trajectory. The healthcare M&A market remains active, presenting opportunities for Wellgistics to pursue accretive acquisitions.
- Development of Value-Added Services: Offering additional value-added services, such as data analytics, regulatory compliance support, and marketing assistance, can differentiate Wellgistics from its competitors and attract more customers. By providing comprehensive solutions that address the evolving needs of independent pharmacies and pharmaceutical manufacturers, the company can strengthen its customer relationships and increase its revenue per customer. The market for value-added services in the pharmaceutical industry is growing rapidly, driven by increasing regulatory complexity and the need for data-driven decision-making.
What Opportunities Does WGRX Have?
- Expansion of the DelivMeds platform.
- Strategic partnerships with pharmaceutical manufacturers.
- Geographic expansion within the United States.
- Acquisition of complementary businesses.
What Threats Does WGRX Face?
- Intense competition from established pharmaceutical distributors.
- Stringent regulatory requirements.
- Fluctuations in pharmaceutical pricing.
- Economic downturn affecting healthcare spending.
What Are WGRX's Competitive Advantages?
- DelivMeds Platform: The DelivMeds platform provides a unique service offering, creating a sticky customer base among independent pharmacies.
- Third-Party Logistics Expertise: Specialized logistics services for pharmaceutical manufacturers offer a competitive advantage.
- Established Distribution Network: A network of pharmacies and manufacturers provides a barrier to entry for new competitors.
What Does WGRX Do?
Wellgistics Health, Inc., formerly known as Danam Health, Inc., was incorporated in 2022 and is headquartered in Tampa, Florida. The company underwent a name change in October 2024 to better reflect its evolving business strategy. Wellgistics operates as a wholesaler and distributor of a wide array of pharmaceutical products, including both generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. These products are distributed to pharmaceutical manufacturers and independent retail pharmacies across the United States. In addition to its core distribution services, Wellgistics offers comprehensive third-party logistics solutions. These services encompass warehousing, inventory management, pick and pack operations, and shipping, tailored to meet the needs of small and mid-size pharmaceutical manufacturers. This end-to-end logistics support enables manufacturers to focus on their core competencies while ensuring efficient and reliable product delivery. A key component of Wellgistics' offering is the DelivMeds platform, designed as a pharmaceutical hub. This platform facilitates the seamless transfer of prescriptions and provides backend clinical concierge services to a network of independent pharmacies. By streamlining prescription management and offering clinical support, DelivMeds aims to enhance the operational efficiency and service quality of its pharmacy partners. Wellgistics also operates a retail community specialty, further expanding its reach within the pharmaceutical ecosystem.
What Products and Services Does WGRX Offer?
- Wholesales and distributes generic and branded pharmaceuticals.
- Distributes over-the-counter healthcare and consumer products.
- Provides third-party logistics services, including warehousing and inventory management.
- Offers pick and pack services for pharmaceutical products.
- Manages shipping and delivery to small and mid-size pharmaceutical manufacturers.
- Operates the DelivMeds platform, a pharmaceutical hub.
- Facilitates prescription transfers through the DelivMeds platform.
- Provides backend clinical concierge services to independent pharmacies.
How Does WGRX Make Money?
- Generates revenue through the wholesale distribution of pharmaceutical products.
- Earns fees for providing third-party logistics services to pharmaceutical manufacturers.
- Monetizes the DelivMeds platform by charging fees for prescription transfers and clinical concierge services.
What Industry Does WGRX Operate In?
The pharmaceutical distribution industry is characterized by intense competition and stringent regulatory requirements. Major players dominate the market, but there is a growing demand for specialized services catering to independent pharmacies and smaller pharmaceutical manufacturers. Wellgistics Health, Inc. operates in this niche, leveraging its DelivMeds platform and third-party logistics services to differentiate itself. The industry is experiencing growth driven by an aging population, increasing prevalence of chronic diseases, and advancements in pharmaceutical research and development. Wellgistics aims to capitalize on these trends by providing efficient and reliable distribution solutions to its target market.
Who Are WGRX's Key Customers?
- Independent retail pharmacies across the United States.
- Small and mid-size pharmaceutical manufacturers.
- Healthcare providers utilizing the DelivMeds platform.
WGRX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that those closest to the business believe in its potential.
- Social sentiment has shifted positively, with community discussions highlighting the company's innovative approaches in the health sector.
- Increased media coverage has spotlighted Wellgistics Health's unique solutions, fostering a more favorable public perception.
- Recent partnerships with health organizations have strengthened its market position, suggesting growth opportunities ahead.
Bear Case
- Concerns about regulatory challenges in the health sector have emerged, leading to skepticism about the company's operational stability.
- Community sentiment has shown some volatility, with mixed opinions on the company's long-term viability amid competition.
- Recent earnings reports have raised questions about profitability, causing some investors to reassess their positions.
- Market perception remains cautious due to broader economic uncertainties impacting the healthcare industry as a whole.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
WGRX Latest News
-
12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga · May 21, 2026
-
Crude Oil Moves Higher; Walmart Shares Fall After Q1 Results
benzinga · May 21, 2026
-
US Stocks Lower; Nvidia Posts Upbeat Earnings
benzinga · May 21, 2026
-
12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga · May 21, 2026
WGRX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for WGRX.
Price Targets
Wall Street price target analysis for WGRX.
WGRX MoonshotScore
What does this score mean?
The MoonshotScore rates WGRX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
12 Health Care Stocks Moving In Thursday's Intraday Session
Crude Oil Moves Higher; Walmart Shares Fall After Q1 Results
US Stocks Lower; Nvidia Posts Upbeat Earnings
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Leadership: Prashant Patel
CEO
Prashant Patel serves as the CEO of Wellgistics Health, Inc. His background includes experience in healthcare management and pharmaceutical distribution. Patel has a proven track record of driving growth and innovation in the healthcare sector. He brings a wealth of knowledge in supply chain management, regulatory compliance, and strategic planning to Wellgistics. His leadership is focused on expanding the company's market presence and enhancing its service offerings to meet the evolving needs of its customers.
Track Record: Under Prashant Patel's leadership, Wellgistics Health, Inc. has focused on developing the DelivMeds platform and expanding its third-party logistics services. He has overseen the company's rebranding efforts and strategic shift towards serving independent pharmacies and pharmaceutical manufacturers. Patel's key achievements include establishing partnerships with key industry players and driving innovation in pharmaceutical distribution.
Common Questions About WGRX (Healthcare)
What does Wellgistics Health, Inc. do?
Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products, catering to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes both generic and branded pharmaceuticals, along with over-the-counter healthcare products. Additionally, Wellgistics provides third-party logistics services, including warehousing, inventory management, and shipping. Its DelivMeds platform serves as a pharmaceutical hub, facilitating prescription transfers and offering clinical concierge services to independent pharmacies, aiming to streamline operations and enhance patient care.
What do analysts say about WGRX stock?
Given Wellgistics Health, Inc.'s micro-cap status and financial challenges, analyst coverage may be limited. However, key valuation metrics to consider include its price-to-sales ratio and potential for revenue growth. The company's success hinges on its ability to improve its profit margins and expand its market share within the competitive pharmaceutical distribution industry. Investors should closely monitor the company's progress in leveraging its DelivMeds platform and third-party logistics services to drive sustainable growth and profitability. No analysts have provided ratings at this time.
What are the main risks for WGRX?
Wellgistics Health, Inc. faces several key risks, including intense competition from established pharmaceutical distributors with greater resources and market share. The company's negative profit and gross margins pose a significant financial risk, requiring substantial improvements in operational efficiency and cost management. Changes in pharmaceutical regulations and pricing pressures could also negatively impact its business. Additionally, an economic downturn could reduce healthcare spending, affecting the demand for its products and services. Successfully mitigating these risks is crucial for the company's long-term viability.
What are the key factors to evaluate for WGRX?
Wellgistics Health, Inc. (WGRX) holds an AI score of 49/100 (low). Not financial advice.
How frequently does WGRX data refresh on this page?
WGRX prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven WGRX's recent stock price performance?
Wellgistics Health, Inc. (WGRX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: DelivMeds platform offering clinical concierge services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider WGRX overvalued or undervalued right now?
Valuing Wellgistics Health, Inc. (WGRX) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying WGRX?
Before investing in Wellgistics Health, Inc. (WGRX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on limited publicly available information.
- Analyst coverage may be limited due to the company's micro-cap status.